Session Details

Session Details

10:15 AM - 12:00 PM - Room 318-323

Stephen Russell - MD, PhD - Vyriad

Co-Chair

10:15 AM - 12:00 PM - Room 318-323

Kah-Whye Peng - PhD - Mayo Clinic

Co-Chair

10:15 AM - 10:30 AM - Room 318-323

Neil Desai - AADIGEN

415: KRAS Mutant Gene Editing Abolishes Tumor Growth In Vivo and Overcomes Acquired Resistance to KRAS^G12C and KRAS^G12D Small Molecule Inhibitors

10:30 AM - 10:45 AM - Room 318-323

Susanne Wilde - PhD - SCG Cell Therapy

416: A High-Avidity, CD8-Co-Receptor-Independent, HPV-Specific TCR Coupled with a TGF-β Chimeric Switch Receptor Enhances Polyfunctional Profiles and Anti-Tumor Activities in HPV-16/52-Associated Cancers

10:45 AM - 11:00 AM - Room 318-323

David Suhy - PhD - Earli, Inc

417: Hostile Takeover: Diagnosing Cancer from within Using a Cancer-Activated Genetic Construct as a Novel Imaging Platform for NSCLC Detection

11:00 AM - 11:15 AM - Room 318-323

Daniil Shmidt - MD - Baylor College of Medicine

324: Healthy Donor-Derived Unedited CD7.CAR T-Cells for Improved Therapy of T-Cell Malignancies

11:15 AM - 11:30 AM - Room 318-323

Candace Perullo - TScan Therapeutics

419: Discovery of Tumor Reactive TCRs and Their Cognate Antigenic Targets via High-Throughput Functional Screening

11:30 AM - 11:45 AM - Room 318-323

Kirsten Bowland - PhD - Johns Hopkins University School of Medicine

420: CRISPR-Cas9 Genetic Targeting of Metastatic Pancreatic Cancer

11:45 AM - 12:00 PM - Room 318-323

Selina Shiqing Teh - PhD - Johns Hopkins University School of Medicine

421: CRISPR-Cas9 for Selective Targeting of Somatic Mutations in Pancreatic Cancers: A Novel Cancer Gene Therapy Approach